avasimibe has been researched along with Lung Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, B; Lubet, RA; Palen, K; Pan, J; Qiao, L; Sei, S; Shoemaker, RH; Wang, L; Wang, Y; You, M; Zhang, Q | 1 |
1 other study(ies) available for avasimibe and Lung Neoplasms
| Article | Year |
|---|---|
Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator.
Topics: Acetamides; Acetates; Amino Acid Sequence; Animals; Cancer Vaccines; Cholesterol; Disease Progression; Lung Neoplasms; Mice; Proto-Oncogene Proteins p21(ras); Sulfonamides; Sulfonic Acids; T-Lymphocytes, Regulatory; Vaccines, Subunit | 2019 |